Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.

MLA

Buciuc, Marina, et al. “Utility of FDG-PET in Diagnosis of Alzheimer-Related TDP-43 Proteinopathy.” Neurology, vol. 95, no. 1, July 2020, pp. e23–34. EBSCOhost, https://doi.org/10.1212/WNL.0000000000009722.

APA

Buciuc, M., Botha, H., Murray, M. E., Schwarz, C. G., Senjem, M. L., Jones, T., Knopman, D. S., Boeve, B. F., Petersen, R. C., Jack, C. R., Petrucelli, L., Parisi, J. E., Dickson, D. W., Lowe, V., Whitwel, J. L., Josephs, K. A., Jones, D. T., Jack, C. R., Jr, & Whitwell, J. L. (2020). Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy. Neurology, 95(1), e23–e34. https://doi.org/10.1212/WNL.0000000000009722

Chicago

Buciuc, Marina, Hugo Botha, Melissa E. Murray, Christopher G. Schwarz, Matthew L. Senjem, T. Jones, David S. Knopman, et al. 2020. “Utility of FDG-PET in Diagnosis of Alzheimer-Related TDP-43 Proteinopathy.” Neurology 95 (1): e23–34. doi:10.1212/WNL.0000000000009722.